In global health, many promising innovations struggle to reach their full potential, especially in resource-limited settings. To help address this challenge, the World Health Organization (WHO) and global health leaders could consider establishing a High-Impact Innovations List (HIIL)—a strategic tool to identify and elevate innovations with the greatest potential to improve health outcomes globally. Such lists are not unprecedented as the World Health Organization (WHO) maintains several critical lists to guide global health priorities and ensure equitable access to essential health interventions. One notable example is the Essential Medicines List (EML) created in 1977, to identify and prioritize the most important medicines for public health based on clinical evidence, disease burden, and effectiveness. Regularly updated, the EML guides governments and health organizations in ensuring the availability of essential medicines and prioritizing healthcare resources globally.

Read more here:    

https://blogs.bmj.com/bmjgh/2025/05/12/scaling-up-solutions-the-need-for-a-high-impact-innovations-list/